<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE309nnn/GSE309375/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309375</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Elevated Serum IL-10 in the Setting of Relapsed B-ALL in Patients Previously Treated with CART</name><description>Cytokine release syndrome (CRS) is a life-threatening toxicity of chimeric antigen receptor T-cell therapy (CART) for B-cell acute lymphoblastic leukemia (B-ALL). Lower rates of severe CRS are reported in patients treated with CD22-directed CART (CART22) compared to those treated with CD19-directed CART (CART19). Here, we identify interleukin-10 (IL-10) as a critical endogenous modulator of CRS and demonstrate that previous treatment with CART is associated with increased serum IL-10 in the setting of subsequent relapse. Mechanistically, IL-10 induced higher interferon gamma (IFNγ) expression and SOCS3 upregulation in both CART19 and CART22 cells. IL-10 differentially impacted the CART immune synapse, prolonging the CART19 but shortening the CART22 immune synapse. Using single cell RNA sequencing (scRNAseq) we demonstrate upregulation of SOCS3 in CART22 patient CD4 T-cells, potentially suppressing gp130-mediated IL-6 signaling. These findings reveal IL-10 as a potent CRS‐mitigating factor and support IL-10 enhancement strategies to improve the safety of CART.</description><dates><publication>2026/07/01</publication></dates><accession>GSE309375</accession><cross_references><GSM>GSM9266440</GSM><GSM>GSM9266441</GSM><GSM>GSM9266442</GSM><GSM>GSM9266443</GSM><GSM>GSM9266400</GSM><GSM>GSM9266444</GSM><GSM>GSM9266401</GSM><GSM>GSM9266445</GSM><GSM>GSM9266446</GSM><GSM>GSM9266402</GSM><GSM>GSM9266403</GSM><GSM>GSM9266447</GSM><GSM>GSM9266404</GSM><GSM>GSM9266448</GSM><GSM>GSM9266449</GSM><GSM>GSM9266405</GSM><GSM>GSM9266439</GSM><GSM>GSM9266430</GSM><GSM>GSM9266431</GSM><GSM>GSM9266432</GSM><GSM>GSM9266433</GSM><GSM>GSM9266434</GSM><GSM>GSM9266435</GSM><GSM>GSM9266436</GSM><GSM>GSM9266437</GSM><GSM>GSM9266438</GSM><GSM>GSM9266428</GSM><GSM>GSM9266429</GSM><GSM>GSM9266460</GSM><GSM>GSM9266461</GSM><GSM>GSM9266462</GSM><GSM>GSM9266463</GSM><GSM>GSM9266420</GSM><GSM>GSM9266464</GSM><GSM>GSM9266421</GSM><GSM>GSM9266422</GSM><GSM>GSM9266423</GSM><GSM>GSM9266424</GSM><GSM>GSM9266425</GSM><GSM>GSM9266426</GSM><GSM>GSM9266427</GSM><GSM>GSM9266417</GSM><GSM>GSM9266418</GSM><GSM>GSM9266419</GSM><GSM>GSM9266450</GSM><GSM>GSM9266451</GSM><GSM>GSM9266452</GSM><GSM>GSM9266453</GSM><GSM>GSM9266410</GSM><GSM>GSM9266454</GSM><GSM>GSM9266455</GSM><GSM>GSM9266411</GSM><GSM>GSM9266412</GSM><GSM>GSM9266456</GSM><GSM>GSM9266457</GSM><GSM>GSM9266413</GSM><GSM>GSM9266414</GSM><GSM>GSM9266458</GSM><GSM>GSM9266459</GSM><GSM>GSM9266415</GSM><GSM>GSM9266416</GSM><GSM>GSM9266406</GSM><GSM>GSM9266407</GSM><GSM>GSM9266408</GSM><GSM>GSM9266409</GSM><GPL>24676</GPL><GSE>309375</GSE><taxon>Homo sapiens</taxon><PMID>[42320984]</PMID></cross_references></HashMap>